Written by C. Zoe Hoeppner, PhD

Principal Engineer at Fresenius Kabi (via the recent acquisition of Fenwal Inc), Katherine Radwanski is rising young female star in the apheresis and blood device industry. Despite having only received her Master’s in Biotechnology from Northwestern University in 2008, Katherine has quickly made a name for herself, winning several awards from professional societies, authoring patents, and most recently serving as the technical lead for an exploratory IND (investigational new drug) study at Fenwal (now Fresenius). Traditionally, a company submits IND applications only after a candidate drug has been put through rigorous testing and is in final product form. The study Katherine lead of a new platelet additive solution was one of the first of its kind in the transfusion technology industry, and a major accomplishment for her company.

Though she is a technical whiz when it comes to apheresis, Katherine is not taking anything away but rather giving back through mentoring young women scientists and engineers during their co-op internships at Fresenius Kabi, or through career mentorship. Katherine sees the biggest challenge women facing in her industry are a lack of female mentors in senior technical roles. While she was fortunate, her mother was a great mentor and source of support for her in her education and career; working as a manufacturing engineer for over 30 years where few women can be found; this is often not the case. As Katherine sees it, often time’s female scientists and engineers with excellent communication and management skills are diverted to the project management roles, which leave a gap for mentors to the more junior female scientists. For her part, Katherine is trying to overcome this issue by encouraging women to pursue their technical interests through continuous learning and educating them on how they can advance their careers in a technical path as she has.